1. Correction to: Acute respiratory failure and the kinetics of neutrophil recovery in pediatric hematopoietic cell transplantation: a multicenter study
- Author
-
Moffet, J. R., Mahadeo, K. M., McArthur, J., Hsing, D. D., Gertz, S. J., Smith, L. S., Loomis, A., Fitzgerald, J. C., Nitu, M. E., Duncan, C. N., Hall, M. W., Pinos, E. L., Tamburro, R. F., Simmons, R. A., Troy, J., Cheifetz, I. M., and Rowan, C. M.
- Subjects
Kinetics ,Respiratory Distress Syndrome ,Transplantation ,Neutrophils ,Haematopoietic stem cells ,Health care ,Hematopoietic Stem Cell Transplantation ,Correction ,Humans ,Hematology ,Child ,Respiratory Insufficiency ,Respiration, Artificial - Abstract
In this multicenter study, we investigated the kinetics of neutrophil recovery in relation to acuity and survival among 125 children undergoing allogeneic hematopoietic cell transplantation (allo-HCT) who required invasive mechanical ventilation (IMV). Recovery of neutrophils, whether prior to or after initiation of IMV, was associated with a significantly decreased risk of death relative to never achieving neutrophil recovery. A transient increase in acuity (by oxygenation index and vasopressor requirements) occurred among a subset of the patients who achieved neutrophil recovery after initiation of IMV; 61.5% of these patients survived to discharge from the intensive care unit (ICU). Improved survival among patients who subsequently achieved neutrophil recovery on IMV was not limited to those with peri-engraftment respiratory distress syndrome. The presence of a respiratory pathogen did not affect the risk of death while on IMV but was associated with an increased length of IMV (p 0.01). Among patients undergoing HCT who develop respiratory failure and require advanced therapeutic support, neutrophil recovery at time of IMV and/or presence of a respiratory pathogen should not be used as determining factors when counseling families about survival.
- Published
- 2019
- Full Text
- View/download PDF